The clinical correlation study and the effect of fluoxetine intervention on poststroke depression

Chinese Journal of Clinical Rehabilitation

Volumn 6, Issue 15, 2002, Pages 2296-2297

  Huang, Xing Han ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Fluoxetine; Neurological function; Poststroke depression

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPRESSION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; HAMILTON SCALE; HUMAN; INTELLIGENCE TEST; MAJOR CLINICAL STUDY; STROKE PATIENT; TREATMENT OUTCOME;

EID: 2442527951     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. EBRAHIMS, BARER O, NOURL F. Affective illness after stroke[J]. Br J Psy Chiatry, 1987, 151: 52.
2. ALLAN HOUSE, PETER KNAPP, JOHN BAMFORD. Mortality at and 24 months after stroke may be associated with depressive symptoms at 1 month[J]. Stroke, 2001, 32: 696.
3. ASTROM M, ADOLFSSON R, ASPLUND K. Major depression in stroke patients a 3-year longitudinal study[J]. Stroke, 1993, 24: 976.
4. WIART L, PETIT H, JOSEPH A, et al. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study[J]. Stroke, 2000, 31: 1829.
5. ROBERT G, SUSAN K, CARLOS C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study[J]. Am J Psychiatry, 2000, 157: 351.